TECH Dividend History & Description — Techne Corporation
Techne and subsidiaries are engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. Co. has two segments: biotechnology and hematology. Co.'s biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products. Co., through its biotechnology segment, supplies proteins such as cytokines and related reagents. Co. also produces and markets enzymes and intracellular signaling reagents. Co. also markets one type of immunoassay kit under the trade name Quantikine®. Co.'s hematology segment develops and manufactures hematology controls and calibrators for both impedance and laser type cell counters.